FDA  Approves Elan's Non-Narcotic Painkiller Prialt
14679
Biotech company Elan Corp. reported Tuesday that the Food and Drug Administration approved its non-narcotic painkiller Prialt to treat chronic pain.
175332
The Food and Drug Administration yesterday approved the first birth control pill that  eliminates a woman's monthly period.
318018
(WASHINGTON) - The maker of a new drug to treat women&#39;s sexual dysfunction says the product is safe and should be approved without delay.
64073
Tysabri, a treatment for multiple sclerosis, received regulatory approval on Monday for use among patients with Crohnâs disease.
597488
The U.S. Food and Drug  Administration said on Monday it had approved Cephalon Inc.'s  drug Fentora to treat pain in certain cancer patients.
14315
The Food and Drug Administration has approved a new sleeping pill that some specialists say could pave the way for longer-term use of such medications.
221218
The government approved a drug Tuesday that offers a new way of fighting severe pain &#151; an option for patients who no longer benefit from morphine and other traditional pain medications.
138734
The US Food and Drug Administration has approved a chewable non-calcium drug that can help kidney patients on dialysis manage their phosphorus levels.
149931
SAN FRANCISCO (CBS.MW) -- Shares of Elan Corp. and Biogen Idec rose in premarket trade Wednesday after the US Food and Drug Administration approved the companies&#39; multiple sclerosis drug Tysabri.
79616
AstraZeneca Plc, the UK&#39;s second largest drugmaker, said US regulators approved its ulcer treatment Nexium for use in reducing the risk of stomach ulcers in patients taking certain painkillers
446718
The US Food and Drug Administration has approved Eli Lilly&#39;s Cymbalta, a balanced and potent serotonin and norepinephrine reuptake inhibitor.
564004
Tysabri, a treatment for multiple sclerosis made by Biogen Idec Inc. and Elan Corp., received regulatory approval on Monday for use among patients with a severe intestinal disorder.
563410
25/11/2004 - The first in a completely new class of drug for multiple sclerosis has been approved in the US, opening up a new avenue of treatment for sufferers of the debilitating diseases and potential blockbuster revenues for developers Elan and Biogen
648215
DePuy Spine, Inc., a Johnson &amp; Johnson company (NYSE: JNJ), said that the US Food and Drug Administration (FDA) has approved the first artificial disc for treatment of low back pain.
205700
Elan shares jumped this morning after it said that US regulators had approved it new once-a-month multiple sclerosis drug. Tysabri, developed by Elan and Biogen and formerly called Antegren, is the first kind
753742
QLT Inc. (QLT.TO: Quote, Profile, Research) (QLTI.O: Quote, Profile, Research) said on Wednesday it won US regulatory approval for the six-month formulation of its prostate cancer treatment, Eligard.
425560
U.S. regulators approved the first generic rival to Johnson & Johnson's Duragesic pain relief skin patch, the U.S. Food and Drug Administration said on Friday.